[Literature Library] Human milk oligosaccharides (HMOs) and the prevention of necrotizing enterocolitis

1 min read /
Clinical Nutrition Gastroenterology Neonatology Gut health Nutrition & Disease Management
[Literature Library] Human milk oligosaccharides (HMOs) and the prevention of necrotizing enterocolitis

This review paper takes reader through the almost 20-year long journey in the research of human milk oligosaccharides (HMOs) in the prevention of necrotizing enterocolitis (NEC), including recent human mother-infant cohort studies that confirmed specific HMOs are associated with lower NEC risk.

Save (for later)

Link to Publication: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6288465/pdf/fped-06-00385.pdf

 

 

Reference

Bode L. Human milk oligosaccharides in the prevention of necrotizing enterocolitis: A journey from in vitro and in vivo models to mother-infant cohort studies. Front Pediatr.2018;36:385.
 

WYE-EM-017-JAN-19

If you liked this post you may also like

allergy

[Guideline Summary] S3 guidelines on allergy prevention

vaccination

[Literature library] Coronavirus Disease 2019 (COVID-19) mRNA-based vaccination and breastfeeding

boy-in-toilet

[Literature library] High sn-2 palmitate infant formula and gastrointestinal (GI) tolerance

gut-puzzles

[Literature library] Bovine milk oligosaccharides (MOS) support gut microbiota development and intestinal immune defense